411 REFERENCE · Wikibooks
Radiation Oncology/RTOG Trials/8519
Reference material by Wikibooks contributors. This retains its source identity and is not 411 news reporting.
RTOG 85-19 (PROSTATE)
Title: Phase II (title not available)
Objectives: (not available)
Protocol: (not available)
Eligibility: Bulky primary lesions, stage B2 and C, with disease confined to the pelvis
Enrolled: 31 patients
Conclusion:
2146872 -- Phase II Radiation Therapy Oncology Group study of hormonal cytoreduction with flutamide and Zoladex in locally advanced carcinoma of the prostate treated with definitive radiotherapy. (Pilepich MV, Am J Clin Oncol 1990). Conclusion: The observed toxicity appears acceptable and the response rate encouraging.